用户名:  密码:   
网站首页即时通讯活动公告最新消息科技前沿学人动向两岸三地人在海外历届活动关于我们联系我们申请加入
栏目导航 — 美国华裔教授专家网最新消息社区报道
关键字  范围   
 
The FDA has recently approved the following devices to be marketed.
2024/10/13 20:33:36 | 浏览:505 | 评论:0

The FDA has recently approved the following devices to be marketed.

Occlutech ASD Occluder and Occlutech Pistol Pusher – P200032

The Occlutech ASD Occluder is a permanent implant intended to treat an atrial septal defect (ASD). The device has two umbrella-shaped flexible discs with a connection in the middle. When the device is carefully positioned in the ASD, the two discs cover both sides of the atrial septum, closing the hole. After a few months, the device will be covered by a thin layer of tissue.

The FDA has recently approved the following devices to be marketed.

TZ Medical Adult and Pediatric Multi-Function Defibrillation Electrodes and Adaptors – P200005

TZ Medical Multi-Function Defibrillation Electrodes and Adaptors monitor the heart’s rhythm and deliver a pacing or electrical shock from a defibrillator(a device that applies an electric charge to the heart to restore a normal heartbeat)to a person with an arrhythmia.

The FDA has recently approved the following devices to be marketed.


Edwards EVOQUE Tricuspid Valve Replacement System – P230013

The Edwards EVOQUE Tricuspid Valve Replacement System mainly includes an artificial tricuspid valve(called the EVOQUE valve)and a delivery catheter. The EVOQUE valve is made of cow tissue attached to a self-expanding metal(nickel-titanium)frame for support. It can be used to replace the tricuspid valve of the heart without open-heart surgery. The tricuspid valve prevents backflow of blood into the right atrium(upper right chamber of the heart)from the right ventricle(lower right chamber of the heart).

The FDA has recently approved the following devices to be marketed.

Spectra WaveWriter, WaveWriter Alpha, WaveWriter Alpha Prime Spinal Cord Stimulation Systems - P030017/S363

Boston Scientific’s WaveWriter Spinal Cord Stimulation(SCS)Systems are implanted(placed into the body)to help reduce pain that is chronic(long-term)and intractable(difficult to manage)in the legs, arms, or trunk. This supplement expands the Indications for Use to include treatment of low back and leg pain that is difficult to manage without prior back surgery.

The FDA has recently approved the following devices to be marketed.

XACT Carotid Stent System – P040038/S043

The XACT Carotid Stent System is intended to be used to reopen narrowed parts of the carotid arteries in the neck that supply blood to the brain. The system consists of a delivery catheter and a self-expanding metal stent made of nitinol.
This approval expands the indications for the XACT Carotid Stent System to be used during a Transcarotid Artery Revascularization(TCAR)procedure, in which a device is placed in the neck instead of in the thigh in combination with the ENROUTE Transcarotid Neuroprotection System(ENROUTE NPS). The ENROUTE NPS temporarily reverses blood flow at the treatment area to redirect pieces that may become loose during the procedure from potentially traveling to the brain.

The FDA has recently approved the following devices to be marketed.

Xstim Spine Fusion Stimulator – P230025

The Xstim Spine Fusion Stimulator is a bone growth stimulator(BGS)device intended be used on the lower back. The device components include a controller for creating signals, a belt clip, a rechargeable lithium-ion battery pack and charging unit, controller cables, hydrogel electrode pads that stick to the skin, optional electrode covers, including some for use only when showering, and a carry case.

The FDA has recently approved the following devices to be marketed.

INTELLANAV STABLEPOINT™ Ablation Catheter & Force Sensing System on the RHYTHMIA HDX™ Mapping System - P150005/S074

The INTELLANAV STABLEPOINT Ablation Catheter uses radiofrequency(RF)energy applied by the catheter tip to destroy heart tissue cells that are causing heart rhythm problems(arrhythmias).

The FDA has recently approved the following devices to be marketed.

 

Vercise PC, Vercise Gevia, and Vercise Genus Deep Brain Stimulation Systems – P150031/S064

The Vercise PC, Vercise Gevia, and Vercise Genus Deep Brain Stimulation(DBS)Systems are implantable devices that deliver low-intensity electrical pulses to nerve centers in the brain. This supplement expands the Indications for Use to include an option of two-sided stimulation for people who are diagnosed with essential tremor not adequately controlled by medication and where the tremor creates a significant inability to function.

The FDA has recently approved the following devices to be marketed.

AGENT Paclitaxel-Coated Balloon Catheter – P230035

The AGENT Paclitaxel-Coated Balloon Catheter(Agent DCB)uses a narrow tube with a balloon on the end to reopen arteries that supply blood to the heart and are blocked or narrowed due to coronary artery disease(CAD). The balloon is coated on its outer surface with the drug paclitaxel, which may help prevent the arteries from narrowing again(restenosis).

The FDA has recently approved the following devices to be marketed.

LIAISON Biotrin Parvovirus B19 IgG Plus, LIAISON Biotrin Control Parvovirus B19 IgG Plus – P220034

The LIAISON Biotrin Parvovirus B19 IgG Plus is a laboratory test used to detect human parvovirus IgG antibodies against the parvovirus B19 antigen in the blood.

The FDA has recently approved the following devices to be marketed.

 

TriClip G4 System – P230007

The TriClip G4 System is used to treat tricuspid regurgitation(leaky tricuspid valve)often caused by an enlarged heart or damaged tricuspid valve leaflets, without open-heart surgery.

The FDA has recently approved the following devices to be marketed.

ColoSense – P230001

ColoSense is a laboratory test that measures ribonucleic acid(RNA)and hemoglobin(blood)in human stool that is not visible to the eye(fecal occult blood), which may indicate the presence of colorectal cancer or of advanced adenomas(growths on the lining of the colon or rectum). The ColoSense Collection Kit consists of a container for collection of stool and a separate sampler for collection of stool for hemoglobin testing(only one stool is required to obtain both samples). Both samples are required to obtain a ColoSense result. Additionally, bowel prep or following dietary or medication restrictions to complete the test is not necessary.


相关栏目:『社区报道
大学教育已经走进了死胡同 | 德莱塞维茨 2024-11-16 [50]
特朗普宣布获胜|丁学良教授分析:世界将巨变 2024-11-12 [153]
毁掉的一代:极左意识形态下的美国大学 2024-11-12 [129]
佐治亚理工大学撤出中国,夹缝中的中外合办大学感到寒意 2024-11-06 [301]
周敏博士名列2024年世界顶尖华人社会学家榜首 2024-11-06 [305]
82名诺奖得主就美国大选发布公开信 2024-11-04 [360]
加州数十间银行被盗,原来南美职业大盗偷豪宅只是副业 2024-11-04 [328]
德州真牛!新规:医院看病要查身份,非公民账单,直接找联邦要钱! 2024-11-04 [331]
给你开个眼,美国左疯性别 2024-11-03 [390]
驻美大使馆发公告:华人用美金换人民币成功后,中国账户遭封禁 2024-11-03 [387]
相关栏目更多文章
最新图文:
:天安门广场喜迎“十一”花团锦簇的美丽景象 马亮:做院长就能够发更多论文?论文发表是不是一场“权力的游戏”? :印裔人才在美碾压华裔:我们可以从印度教育中学到什么? :北京452万人将从北京迁至雄安(附部分央企名单) :《2019全球肿瘤趋势报告》 :阿尔茨海默病预防与干预核心讯息图解 :引力波天文台或有助搜寻暗物质粒子 :Sail Through the Mist - SoCal Innovation Forum 2019(10/5)
更多最新图文
更多《即时通讯》>>
 
打印本文章
 
您的名字:
电子邮件:
留言内容:
注意: 留言内容不要超过4000字,否则会被截断。
未 审 核:  是
  
关于我们联系我们申请加入后台管理设为主页加入收藏
美国华裔教授专家网版权所有,谢绝拷贝。如欲选登或发表,请与美国华裔教授专家网联系。
Copyright © 2024 ScholarsUpdate.com. All Rights Reserved.